| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Diabetes in older adults: a consensus report.
|
J Am Geriatr Soc
|
2012
|
3.63
|
|
2
|
Diabetes in older adults.
|
Diabetes Care
|
2012
|
3.62
|
|
3
|
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
|
Diabetes
|
2002
|
2.98
|
|
4
|
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.
|
J Allergy Clin Immunol
|
2011
|
2.53
|
|
5
|
High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.
|
Diabetes
|
2002
|
2.36
|
|
6
|
An official American Thoracic Society Workshop report: obesity and asthma.
|
Proc Am Thorac Soc
|
2010
|
2.05
|
|
7
|
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.
|
Diabetes
|
2002
|
1.94
|
|
8
|
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
|
Circulation
|
2011
|
1.81
|
|
9
|
The evolving role of inflammation in obesity and the metabolic syndrome.
|
Curr Diab Rep
|
2005
|
1.66
|
|
10
|
Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians.
|
Atherosclerosis
|
2002
|
1.60
|
|
11
|
Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?
|
Nat Clin Pract Endocrinol Metab
|
2007
|
1.29
|
|
12
|
Obesity and asthma: an inflammatory disease of adipose tissue not the airway.
|
Am J Respir Crit Care Med
|
2012
|
1.28
|
|
13
|
Sex differences in the human brain's response to hunger and satiation.
|
Am J Clin Nutr
|
2002
|
1.25
|
|
14
|
Taste preferences and body weight changes in an obesity-prone population.
|
Am J Clin Nutr
|
2004
|
1.17
|
|
15
|
Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes.
|
J Clin Endocrinol Metab
|
2008
|
1.09
|
|
16
|
Amyloid precursor protein expression is upregulated in adipocytes in obesity.
|
Obesity (Silver Spring)
|
2008
|
1.00
|
|
17
|
Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies.
|
Am J Geriatr Pharmacother
|
2011
|
0.97
|
|
18
|
Ezetimibe/simvastatin or atorvastatin for the treatment of hypercholesterolemia in patients with the metabolic syndrome: the VYMET study.
|
Curr Diab Rep
|
2010
|
0.96
|
|
19
|
Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals.
|
Neuroendocrinology
|
2009
|
0.96
|
|
20
|
Adipose tissue dysfunction in polycystic ovary syndrome.
|
Curr Diab Rep
|
2011
|
0.95
|
|
21
|
Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion.
|
Am J Physiol Endocrinol Metab
|
2008
|
0.95
|
|
22
|
Sexually dimorphic diet-induced insulin resistance in obese tissue inhibitor of metalloproteinase-2 (TIMP-2)-deficient mice.
|
Endocrinology
|
2011
|
0.90
|
|
23
|
The cannabinoid CB1 receptor is expressed in pancreatic delta-cells.
|
Biochem Biophys Res Commun
|
2008
|
0.90
|
|
24
|
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus.
|
Am J Med
|
2009
|
0.90
|
|
25
|
Clinical measures of islet function: usefulness to characterize defects in diabetes.
|
Curr Diabetes Rev
|
2008
|
0.90
|
|
26
|
Advances in the treatment of prediabetes.
|
Ther Adv Endocrinol Metab
|
2010
|
0.89
|
|
27
|
Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure.
|
J Clin Endocrinol Metab
|
2010
|
0.86
|
|
28
|
Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCR.
|
J Alzheimers Dis
|
2012
|
0.85
|
|
29
|
Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight.
|
Metabolism
|
2004
|
0.84
|
|
30
|
Beta-cell function in mild type 2 diabetic patients: effects of 6-month glucose lowering with nateglinide.
|
Diabetes Care
|
2005
|
0.83
|
|
31
|
Sweet taste receptors regulate basal insulin secretion and contribute to compensatory insulin hypersecretion during the development of diabetes in male mice.
|
Endocrinology
|
2014
|
0.83
|
|
32
|
The impact of diabetes and diabetes medications on bone health.
|
Endocr Rev
|
2015
|
0.82
|
|
33
|
Insulin resistance increases PAI-1 in the heart.
|
Biochem Biophys Res Commun
|
2006
|
0.82
|
|
34
|
Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism.
|
PLoS One
|
2012
|
0.82
|
|
35
|
Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus.
|
Eur J Intern Med
|
2009
|
0.81
|
|
36
|
Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age.
|
Life Sci
|
2006
|
0.81
|
|
37
|
The PROactive Study: pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes.
|
Curr Diab Rep
|
2006
|
0.80
|
|
38
|
GIP: an inconsequential incretin or not?
|
Diabetes Care
|
2010
|
0.80
|
|
39
|
Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte.
|
J Cardiopulm Rehabil Prev
|
2007
|
0.80
|
|
40
|
Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%.
|
Endocr Pract
|
2013
|
0.80
|
|
41
|
COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES.
|
Endocr Pract
|
2015
|
0.78
|
|
42
|
UCP5/BMCP1 transcript isoforms in human skeletal muscle: relationship of the short-insert isoform with lipid oxidation and resting metabolic rates.
|
Mol Genet Metab
|
2002
|
0.77
|
|
43
|
Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program.
|
Endocr Pract
|
2011
|
0.77
|
|
44
|
The quality of fat in the diet and its impact on insulin sensitivity.
|
Curr Diab Rep
|
2002
|
0.76
|
|
45
|
Beta-cell preservation…Is weight loss the answer?
|
Rev Diabet Stud
|
2012
|
0.75
|
|
46
|
Does the metabolic syndrome carry additional risk for myocardial infarction?
|
Curr Diab Rep
|
2011
|
0.75
|
|
47
|
LAP-BAND or medical therapy for metabolic syndrome?
|
Curr Diab Rep
|
2008
|
0.75
|
|
48
|
The DREAM Trial: using ramipril and rosiglitazone to prevent diabetes.
|
Curr Diab Rep
|
2007
|
0.75
|
|
49
|
Effects of improving insulin sensitivity on nontraditional cardiovascular risk factors in patients with type 2 diabetes.
|
Curr Diab Rep
|
2003
|
0.75
|
|
50
|
Weight loss and diets: which diet works best?
|
Curr Diab Rep
|
2009
|
0.75
|
|
51
|
On rendering continuous glucose monitoring ready for prime time in the cardiac care unit.
|
Coron Artery Dis
|
2007
|
0.75
|
|
52
|
Type 2 diabetes is one of the leading causes of premature morbidity and mortality. Introduction.
|
Am J Med
|
2013
|
0.75
|